Prostate cancer. Primary hormonal treatment
โ Scribed by L Denis
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 920 KB
- Volume
- 71
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## BACKGROUND. We studied the extent of neuroendocrine (NE) tumor cell differentiation and its relation to regressive changes in prostate cancer after 3-month hormonal treatment. METHODS. Radical prostatectomy specimens from 103 patients, randomized to 3-month neoadjuvant LH-RH-analogue treatment (
Salvage radical prostatectomy and salvage cryotherapy are greatly underused as potentially curative treatments in patients with recurrent prostate cancer after initial radiation therapy.
## Background: I review the data published during the last 5 years on the effects of early treatment of prostate cancer on survival. ## Methods: Data from prospective and randomized studies as well as from population-based studies are presented. ## Results: Two studies (european organization fo
## Abstract Over a half century ago, Charles Huggins demonstrated the response of prostate cancer to androgen deprivation therapy. Subsequently, many discoveries and evolving findings continued to support a research rationale focused on the androgen receptor (AR) as a key target for prostate cancer